China biosynthesis start-up Bluepha raises $58m
Bluepha, a Chinese start-up focused on bio-based chemicals, has raised CNY 400m (USD 58m) in a fourth tranche of Series B funding.
The round was led by Beijing-based Zhong Ping Capital with participation from state-owned Jiangsu Huanghai Financial Holding Group. The company has also secured a CNY 500m credit line from SPD Silicon...
More on Greater China
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.